Cellectis S.A. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 | $0 |
DMAC
DiaMedica Therapeutics Inc. |
$5.43 | $97.19 M | -4.74 | 18 | $0 |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
ERYP
ERYTECH Pharma S.A. |
$0.78 | $47.38 M | -78 | 49 | $0 |
FHTX
Foghorn Therapeutics Inc. |
$4.66 | $332.53 M | -2.73 | 112 | $22.60 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
GNFT
Genfit S.A. |
$3.80 | $269.95 M | -8.62 | 169 | $28.57 M |
HCWB
HCW Biologics Inc. |
$0.41 | $39.35 M | -1.37 | 45 | $2.84 M |
INBX
Inhibrx Biosciences, Inc. |
$16.52 | $241.02 M | -1.44 | 166 | $1.80 M |
IPHA
Innate Pharma S.A. |
$1.88 | $233.63 M | -28.9 | 168 | $51.90 M |
KYMR
Kymera Therapeutics, Inc. |
$39.90 | $2.02 B | -13.13 | 188 | $47.07 M |
KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 | $0 |
NBSE
NeuBase Therapeutics, Inc. |
$0.38 | $1.42 M | -0.02 | 37 | $0 |
NRIX
Nurix Therapeutics, Inc. |
$19.22 | $930.10 M | -5.89 | 286 | $54.55 M |
PASG
Passage Bio, Inc. |
$0.76 | $73.04 M | -0.77 | 58 | $0 |
RGNX
REGENXBIO Inc. |
$8.19 | $693.52 M | -2.4 | 344 | $90.24 M |
SGTX
Sigilon Therapeutics, Inc. |
$22.47 | $56.22 M | -1.52 | 62 | $12.94 M |
SLNO
Soleno Therapeutics, Inc. |
$45.90 | $1.66 B | -22.01 | 92 | $0 |
STTK
Shattuck Labs, Inc. |
$1.27 | $333.81 M | -3.64 | 75 | $1.66 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
